CRP and metabolic dysfunction-associated steatotic liver disease: C-reactive protein-triglyceride glucose index (CTI) represents an innovative composite marker that integrates key components - C-reactive protein (CRP), triglycerides, and glucose—each of which has been robustly associated with diabetes, non-alcoholic fatty liver disease, and cardiovascular events (8–10).